GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)

NSE:GLAXO Revenue

In the fiscal year ending March 31, 2026, GlaxoSmithKline Pharmaceuticals had annual revenue of 38.22B INR with 1.93% growth. GlaxoSmithKline Pharmaceuticals had revenue of 9.95B in the quarter ending March 31, 2026, with 2.15% growth.

• Revenue: 38.22B
• Revenue Growth: +1.93%
• P/S Ratio: 9.60
• Revenue / Employee: 12.28M
• Employees: 3,113
• Market Cap: 366.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	38.22B	724.60M	1.93%
Mar 31, 2025	37.49B	2.96B	8.56%
Mar 31, 2024	34.54B	2.02B	6.21%
Mar 31, 2023	32.52B	-263.06M	-0.80%
Mar 31, 2022	32.78B	3.52B	12.05%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 8, 2026

Data Sources Report a data error